Protagenic Therapeutics (PTIX) Key Ratios
$0.91
$0.02
(2.24%)
As on 27-Aug-2026 13:41EDT
Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | 79.88 | -45.91 | -171.05 | -203.01 |
| Net Profit | -- | 80.95 | 6.67 | -18.07 | -147.05 |
| EPS | -- | 61.04 | -213.52 | -207.38 | -192.74 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-25 | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 139.01 | 54.39 | 747.54 | -236.05 | -94.47 |
| Return on Capital
| -302.69 | -206.99 | -580.54 | -236.05 | -91.49 |
| Return on Assets
| -169.71 | -124.43 | -252.26 | -175.98 | -80.90 |
| Debt to Equity (x)
| -- | -- | -1.32 | -- | -- |
Profitability
ROCE
-580.54
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-580.54
|
-236.05
|
-91.49
|
-40.59
|
-86.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
747.54
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
747.54
|
-236.05
|
-94.47
|
-42.18
|
-102.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-252.26
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-252.26
|
-175.98
|
-80.90
|
-37.24
|
-75.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-45.91
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-45.91
|
-22.05
|
-32.45
|
17.44
|
-62.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
6.67
--
Year on year growth in profit after tax
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
6.67
|
-10.50
|
-40.61
|
21.38
|
-77.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-2.14
--
Year on year growth in earnings per share
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-2.14
|
0.25
|
-0.37
|
-2.13
|
0.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-1.32
--
Total debt / Net worth
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-1.32
|
--
|
--
|
0.05
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.32
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-1.32
|
--
|
--
|
0.05
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.34
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
0.34
|
2.00
|
6.41
|
7.18
|
13.83
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
0.34
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
0.34
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-27.15
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-27.15
|
--
|
-42.04
|
-24.87
|
-8.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
10.40
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
10.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
10,329.23
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
10,329.23
|
787.23
|
1,742.81
|
2,644,671.76
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-0.49
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-0.49
|
-0.58
|
-0.88
|
-0.49
|
-5.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
-1.05
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-1.05
|
3.14
|
1.20
|
0.25
|
2.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.43
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Protagenic Therapeutics (PTIX)
|
-0.43
|
-0.25
|
-0.07
|
1.73
|
-3.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
